Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Shareprice 35% below pp price

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Mar 27, 2024 2:36pm

87 Views

Post# 35956156

RE:RE:RE:Shareprice 35% below pp price

Some smaller hands may have in fact done this, but certainly has not had a profound impact.

I would say the lower share price is helpful if one wants to take a reasonable risk and double one's money. There is fundamentally nothing different between when we trading at 13-14 cents vs now.

Seen it so many times before play out. Buy low, sell high, that's how money is made on penny stocks.

<< Previous

Bullboard Posts

Next >>

Optimi Health makes commercial entry into Australia